Results 141 to 150 of about 958,890 (240)

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

Nature reviews. Drug discovery, 2017
D. Schwartz, Y. Kanno, A. Villarino, Michael Ward, M. Gadina, J. O’Shea   +5 more
semanticscholar   +1 more source

Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis. [PDF]

J Clin Med
Buzoianu O, Satirer Ö, Kuemmerle-Deschner JB, Reiser C.   +3 more
europepmc   +1 more source

From infection to infarction: cytomegalovirus retinitis complicated by retinal ischemia and vitreous hemorrhage in the setting of JAK inhibition - a case report. [PDF]

BMC Ophthalmol
Johnson CD, El Zein L, Yamanuha J.
europepmc   +1 more source

Impact of rare JAK/STAT germline mutations on vaccination-induced innate immune responses in a Tyrolian population. [PDF]

Int J Biol Sci
Hennighausen L, Cho G, Lee SG, Caf Y, Kim J, Knabl L, Furth PA, Lee HK.   +7 more
europepmc   +1 more source

Prostate Cancer, JAK/STAT3 Dysregulation, and Flavonoids: Is There a Possible Link? [PDF]

Int J Mol Sci
Uivarosi V, Miricescu D, Vacaroiu IA, Spinu DA, Stefani C, Stanciu S, Nica RI, Stanescu-Spinu II, Badoiu SC, Nica S, Jinga V.   +10 more
europepmc   +1 more source

JAK-1 inhibitors in the management of atopic dermatitis in patients over 65 years old: a descriptive cohort study. [PDF]

Sci Rep
Zheng J, Robles-Velasco K, Sharma S, de Souza Lima ICA, Pasquini VF, Ducati RG, Lima H.   +6 more
europepmc   +1 more source

JAK-STAT pathway activation compromises nephrocyte function in a <i>Drosophila</i> high-fat diet model of chronic kidney disease. [PDF]

Elife
Zhao Y, Duan J, Seah H, van de Leemput J, Han Z.   +4 more
europepmc   +1 more source

Clinical updates of JAK inhibitors in cutaneous granulomatous diseases. [PDF]

Front Immunol
Gu J, He X, Lu B, Wang J, Chen K, Wang Q, Jian X, Huang C, Yu B.   +8 more
europepmc   +1 more source

Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles. [PDF]

Biomedicines
Aho S, Coste C, Purcari L, Trédan O, Poulard C, Mery B, Boisvert FM, Le Romancer M.   +7 more
europepmc   +1 more source

Quality of Systematic Reviews with Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale. [PDF]

J Clin Med
Ramalho B, Penedones A, Mendes D, Alves C.   +3 more
europepmc   +1 more source